Revised Response Criteria for Malignant Lymphoma
Tóm tắt
Standardized response criteria are needed to interpret and compare clinical trials and for approval of new therapeutic agents by regulatory agencies.
The International Working Group response criteria (Cheson et al, J Clin Oncol 17:1244, 1999) were widely adopted, but required reassessment because of identified limitations and the increased use of [18F]fluorodeoxyglucose-positron emission tomography (PET), immunohistochemistry (IHC), and flow cytometry. The International Harmonization Project was convened to provide updated recommendations.
New guidelines are presented incorporating PET, IHC, and flow cytometry for definitions of response in non-Hodgkin's and Hodgkin's lymphoma. Standardized definitions of end points are provided.
We hope that these guidelines will be adopted widely by study groups, pharmaceutical and biotechnology companies, and regulatory agencies to facilitate the development of new and more effective therapies to improve the outcome of patients with lymphoma.
Từ khóa
Tài liệu tham khảo
Pfistner B, Diehl V, Cheson B: International harmonization of trial parameters in malignant lymphoma. Eur J Haematol Suppl July:53,2005-54,
Jerusalem G, Beguin Y, Fassotte MF, et al: Whole-body positron emission tomography using 18F-fluorodeoxyglucose compared to standard procedures for staging patients with Hodgkin's disease. Haematologica 86:266,2001-273,
Hutchings M, Loft A, Hansen M, et al: Positron emission tomography with or without computed tomography in the primary staging of Hodgkin's lymphoma. Haematologica 91:482,2006-489,
Querellou S, Valette F, Bodet-Milin C, et al: FDG-PET/CT predicts outcome in patients with aggressive non-Hodgkin's lymphoma and Hodgkin's disease. Ann Hematol 15:759,2006-767,
Gallamini A, Rigacci L, Merli F, et al: Predictive value of positron emission tomography performed after two courses of standard therapy on treatment outcome in advanced stage Hodgkin's disease. Haematologica 91:475,2006-481,
Juweid ME, Stroobants S, Hoekstra OS, et al: Use of positron emission tomography for response assessment of lymphoma: Consensus recommendations of the Imaging Subcommittee of the International Harmonization Project in Lymphoma. J Clin Oncol 10.1200/JCO.2006.08.2305
Lewis PJ, Salama A: Uptake of fluorine-18-flouorodeoxyglucose in sarcoidosis. J Nucl Med 35:1647,1994-1649,
Kostakoglu L, Coleman M, Leonard JP, et al: PET predicts prognosis after 1 cycle of chemotherapy in aggressive lymphoma and Hodgkin's disease. J Nucl Med 43:1018,2002-1027,
Copie-Bergman C, Capella C, Motta T, et al: Validation of the GELA scoring system for evaluating gastric biopsies from patients with MALT lymphoma following eradication of . Ann Oncol 16:v94,2005, (suppl 5; abstr 194)Helicobacter pylori
Foltz LM, Song KW, Connors JM: Who actually detects relapse in Hodgkin lymphoma: Patient or physician. Blood 104 (part 1):853a,2004-854a, (abstr 3124)